Literature DB >> 28017778

RhoA S-nitrosylation as a regulatory mechanism influencing endothelial barrier function in response to G+-bacterial toxins.

F Chen1, Y Wang2, R Rafikov2, S Haigh2, W B Zhi3, S Kumar2, P T Doulias4, O Rafikova2, H Pillich5, T Chakraborty5, R Lucas6, A D Verin2, J D Catravas7, J X She3, S M Black2, D J R Fulton8.   

Abstract

Disruption of the endothelial barrier in response to Gram positive (G+) bacterial toxins is a major complication of acute lung injury (ALI) and can be further aggravated by antibiotics which stimulate toxin release. The integrity of the pulmonary endothelial barrier is mediated by the balance of disruptive forces such as the small GTPase RhoA, and protective forces including endothelium-derived nitric oxide (NO). How NO protects against the barrier dysfunction is incompletely understood and our goal was to determine whether NO and S-nitrosylation can modulate RhoA activity and whether this mechanism is important for G+ toxin-induced microvascular permeability. We found that the G+ toxin listeriolysin-O (LLO) increased RhoA activity and that NO and S-NO donors inhibit RhoA activity. RhoA was robustly S-nitrosylated as determined by biotin-switch and mercury column analysis. MS revealed that three primary cysteine residues are S-nitrosylated including cys16, cys20 and cys159. Mutation of these residues to serine diminished S-nitrosylation to endogenous NO and mutant RhoA was less sensitive to inhibition by S-NO. G+-toxins stimulated the denitrosylation of RhoA which was not mediated by S-nitrosoglutathione reductase (GSNOR), thioredoxin (TRX) or thiol-dependent enzyme activity but was instead stimulated directly by elevated calcium levels. Calcium-promoted the direct denitrosylation of WT but not mutant RhoA and mutant RhoA adenovirus was more effective than WT in disrupting the barrier integrity of human lung microvascular endothelial cells. In conclusion, we reveal a novel mechanism by which NO and S-nitrosylation reduces RhoA activity which may be of significance in the management of pulmonary endothelial permeability induced by G+-toxins.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endothelial; G(+)-toxins; Nitric oxide; Permeability; RhoA; S-nitrosylation

Mesh:

Substances:

Year:  2016        PMID: 28017778      PMCID: PMC5768143          DOI: 10.1016/j.bcp.2016.12.014

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  54 in total

Review 1.  Nitrosylation. the prototypic redox-based signaling mechanism.

Authors:  J S Stamler; S Lamas; F C Fang
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

2.  Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation.

Authors:  L Xu; J P Eu; G Meissner; J S Stamler
Journal:  Science       Date:  1998-01-09       Impact factor: 47.728

3.  Nitric oxide reduces NADPH oxidase 5 (Nox5) activity by reversible S-nitrosylation.

Authors:  Jin Qian; Feng Chen; Yevgeniy Kovalenkov; Deepesh Pandey; M Arthur Moseley; Matthew W Foster; Stephen M Black; Richard C Venema; David W Stepp; David J R Fulton
Journal:  Free Radic Biol Med       Date:  2012-03-01       Impact factor: 7.376

4.  S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability.

Authors:  Sébastien Thibeault; Yohann Rautureau; Malika Oubaha; Denis Faubert; Brian C Wilkes; Chantal Delisle; Jean-Philippe Gratton
Journal:  Mol Cell       Date:  2010-08-13       Impact factor: 17.970

5.  Glucosylation and ADP ribosylation of rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling.

Authors:  P Sehr; G Joseph; H Genth; I Just; E Pick; K Aktories
Journal:  Biochemistry       Date:  1998-04-14       Impact factor: 3.162

6.  Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine.

Authors:  Douglas A Mitchell; Michael A Marletta
Journal:  Nat Chem Biol       Date:  2005-07-10       Impact factor: 15.040

7.  Barrier dysfunction and RhoA activation are blunted by homocysteine and adenosine in pulmonary endothelium.

Authors:  Elizabeth O Harrington; Julie Newton; Nicole Morin; Sharon Rounds
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-07-30       Impact factor: 5.464

8.  Aryl Hydrocarbon Receptor Activation in Intestinal Obstruction Ameliorates Intestinal Barrier Dysfunction Via Suppression of MLCK-MLC Phosphorylation Pathway.

Authors:  Bin Han; Baifa Sheng; Zhicao Zhang; Aimin Pu; Jiuheng Yin; Qimeng Wang; Kunqiu Yang; Lihua Sun; Min Yu; Yuan Qiu; Weidong Xiao; Hua Yang
Journal:  Shock       Date:  2016-09       Impact factor: 3.454

Review 9.  Small GTPases in mechanosensitive regulation of endothelial barrier.

Authors:  Konstantin G Birukov
Journal:  Microvasc Res       Date:  2008-09-30       Impact factor: 3.514

10.  Nox5 stability and superoxide production is regulated by C-terminal binding of Hsp90 and CO-chaperones.

Authors:  Feng Chen; Steven Haigh; Yanfang Yu; Tyler Benson; Yusi Wang; Xueyi Li; Huijuan Dou; Zsolt Bagi; Alexander D Verin; David W Stepp; Gabor Csanyi; Ahmed Chadli; Neal L Weintraub; Susan M E Smith; David J R Fulton
Journal:  Free Radic Biol Med       Date:  2015-10-09       Impact factor: 7.376

View more
  5 in total

1.  Analysis of Cysteine Post Translational Modifications Using Organic Mercury Resin.

Authors:  Paschalis-Thomas Doulias; Neal S Gould
Journal:  Curr Protoc Protein Sci       Date:  2018-10-03

2.  Hsp70 Suppresses Mitochondrial Reactive Oxygen Species and Preserves Pulmonary Microvascular Barrier Integrity Following Exposure to Bacterial Toxins.

Authors:  Xueyi Li; Yanfang Yu; Boris Gorshkov; Stephen Haigh; Zsuzsanna Bordan; Daniel Weintraub; Radu Daniel Rudic; Trinad Chakraborty; Scott A Barman; Alexander D Verin; Yunchao Su; Rudolf Lucas; David W Stepp; Feng Chen; David J R Fulton
Journal:  Front Immunol       Date:  2018-06-12       Impact factor: 7.561

3.  Protective role of Cav-1 in pneumolysin-induced endothelial barrier dysfunction.

Authors:  Robert K Batori; Feng Chen; Zsuzsanna Bordan; Stephen Haigh; Yunchao Su; Alexander D Verin; Scott A Barman; David W Stepp; Trinad Chakraborty; Rudolf Lucas; David J R Fulton
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786

Review 4.  Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?

Authors:  Márta L Debreczeni; Zsuzsanna Németh; Erika Kajdácsi; Henriette Farkas; László Cervenak
Journal:  Clin Rev Allergy Immunol       Date:  2021-03-16       Impact factor: 8.667

5.  S-Nitrosylation of RhoGAP Myosin9A Is Altered in Advanced Diabetic Kidney Disease.

Authors:  Qi Li; Delma Veron; Alda Tufro
Journal:  Front Med (Lausanne)       Date:  2021-07-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.